MEDPLUS NSE filing

Medplus Health Services Limited Approves Un-audited Financial Results

The RealCase readMedium impact Neutral

Medplus Health Services Limited approved the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 in their board meeting held on October 31, 2025.

Why it matters

Financial results announcements typically have a medium impact as they provide insights into the company's performance.

The market read

The announcement is about the approval of financial results, which is a routine update. No positive or negative outlook is provided.

* Medplus Health Services Limited approved the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. * The Board of Directors approved the results in their meeting held on October 31, 2025, which commenced at 02:00 PM and concluded at 03:45 PM. * The results are available on the company's website www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. * Consolidated revenue from operations for the quarter ended September 30, 2025, was ₹16,793.29 million, and for the half year ended September 30, 2025, was ₹32,219.63 million. * Consolidated net profit after tax for the quarter ended September 30, 2025, was ₹555.02 million, and for the half year ended September 30, 2025, was ₹978.45 million. * Standalone revenue from operations for the quarter ended September 30, 2025, was ₹2,056.48 million, and for the half year ended September 30, 2025, was ₹3,895.29 million. * Standalone net profit after tax for the quarter ended September 30, 2025, was ₹156.31 million, and for the half year ended September 30, 2025, was ₹291.64 million.

Filing to action

What to do with a filing like this

Medplus Health Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Medplus Health Services Limited. Read the original for the full detail.

View original filing